First Time Loading...

Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 1.8 CAD Market Closed
Updated: Apr 29, 2024

Theratechnologies Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theratechnologies Inc
Cash from Financing Activities Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Theratechnologies Inc
TSX:TH
Cash from Financing Activities
$14.7m
CAGR 3-Years
-26%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Cash from Financing Activities
$81.8m
CAGR 3-Years
-36%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Financing Activities
$842k
CAGR 3-Years
-85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Financing Activities
$142m
CAGR 3-Years
-19%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Financing Activities
-$5.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Cash from Financing Activities
CA$5.4m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
-1%

See Also

What is Theratechnologies Inc's Cash from Financing Activities?
Cash from Financing Activities
14.7m USD

Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Cash from Financing Activities amounts to 14.7m USD.

What is Theratechnologies Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-21%

Over the last year, the Cash from Financing Activities growth was 28%. The average annual Cash from Financing Activities growth rates for Theratechnologies Inc have been -26% over the past three years , -21% over the past five years .